Award
Delivery Order #SPE2DR26FL391
Delivery Order for Dupixent Medication to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$38,613.26
Ceiling
$38,613.26
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26FL391
NAICS
424210
This award represents a delivery order contract under a long-term indefinite delivery/indefinite quantity (IDIQ) agreement with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor in the healthcare sector. The contract facilitates the procurement of Dupixent 300 MG/2 ML PEN, a key medication used in treating certain inflammatory conditions. This delivery order underscores the agency’s ongoing commitment to ensuring reliable access to essential pharmaceutical products critical for patient care. The work involves the timely delivery of specified quantities of Dupixent to support healthcare needs. This contract was issued as a follow-on delivery order under a competitive indefinite delivery vehicle, leveraging an established partnership to enhance supply chain efficiency. The delivery is scheduled for completion within a brief period, reflecting a precise fulfillment timeline. The contract builds on a broader award encompassing multiple pharmaceutical products, allowing the agency to maintain continuous pharmaceutical supply coverage.
Description
4571017416!DUPIXENT 300 MG/2 ML PEN 2ML